Intelligence coverage: 70%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

SNYR

Synergy CHC Corp.

Healthcare · Medicinal Chemicals & Botanical Products

$0.09Sep 17, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Synergy CHC Corp. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -33% YoY in Q1 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue -33% YoY in Q1 FY2026

Pipeline evidence · 0d ago

SNYR's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on SNYR.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2026

Full SNYR earnings analysis

Reported figures for Synergy CHC Corp. — research only, not investment advice.

Revenue YoY
-32.8%
EPS YoY
-330.0%
vs estimates
Miss

Latest Intelligence

Updated

What happened recently for Synergy CHC Corp. (SNYR) — events, not interpretation.

Event
Reported Q1 2026 revenue -33% YoY, miss vs estimates.
Also
Last session September 17, 2026 at $0.09.
Source
Q1 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Synergy CHC Corp. (SNYR)

Healthcare · Medicinal Chemicals & Botanical Products

Investment Snapshot above is the primary AlphaOS analysis for Synergy CHC Corp. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$1.35M
Revenue:
$5.49M

SNYR earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Synergy CHC Corp. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.